1 Min Read
March 16 (Reuters) - Bellerophon Therapeutics Inc
* On March 10, 2017, board appointed Megan Schoeps as principal financial officer of company Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.